Results 71 to 80 of about 51,887 (267)

The pathogenesis of Acanthamoeba infections: current status and future implications

open access: yes, 2004
Acanthamoeba are opportunistic protozoan parasites that can cause painful, visionthreatening keratitis. However the pathogenesis and pathophysiology of Acanthamoeba keratitis remain incompletely understood. Most cases of Acanthamoeba keratitis develop
Khan, Naveed Ahmed
core  

Femtosecond Laser Created Corneal Allogenic Intrastromal Ring Segments for Keratoconus

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background To evaluate the clinical outcomes of femtosecond laser‐created corneal allogenic intrastromal ring segments (femto‐CAIRS) in keratoconic eyes using a newly described nomogram. Methods This retrospective case series recruited 85 eyes from 75 patients.
David J. Gunn   +2 more
wiley   +1 more source

Isolation of Acanthamoeba isolates belonging to T2, T3, T4 and T7 genotypes from environmental samples in Ankara, Turkey

open access: yes, 2004
Acanthamoeba keratitis is a blinding infection that is becoming increasingly important in human health. Early diagnosis is a prerequisite for successful treatment and requires identification of Acanthamoeba at the genotypic level.
Khan, Naveed Ahmed   +4 more
core  

Nocardia keratitis [PDF]

open access: yesQJM: An International Journal of Medicine, 2021
B Gupta   +5 more
openaire   +2 more sources

Duration‐Dependent Efficacy and Clinical Safety of Repeated Low‐Level Red‐Light Therapy for Paediatric Myopia: A Systematic Review and Meta‐Analysis

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background Repeated low‐level red‐light (RLRL) therapy is a novel, non‐invasive intervention for controlling paediatric myopia progression. Despite increasing clinical use, questions remain regarding the magnitude, durability, and safety of treatment effects.
Lee‐Yuan Lin   +8 more
wiley   +1 more source

Recurrent Betaherpetic Keratitis. Therapy Stages and Monitoring Methods of the Disease Dynamics

open access: yesOftalʹmologiâ
Purpose: to propose a step­by­step treatment regimen for betaherpetic keratitis with a method for monitoring the dynamics of the disease.Patients and methods. The study group included 40 patients (40 eyes).
D. Yu. Maychuk   +2 more
doaj   +1 more source

Prevalence, Treatment, and Outcomes of Corneal Disease in Aboriginal and Torres Strait Islander Peoples in Australia: A Systematic Review

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background To synthesise available evidence on the prevalence, treatment strategies, and outcomes of corneal disease affecting Aboriginal and Torres Strait Islander peoples in Australia, and to identify gaps in the existing literature. Methods A systematic review with narrative synthesis was conducted in accordance with PRISMA 2020 guidelines.
Angus van der Nagel   +3 more
wiley   +1 more source

Fungal Keratitis Caused by a New Filamentous Hyphomycete Sagenomella Keratitidis

open access: yes, 2010
A previously undescribed hyphomycetous fungus was isolated from keratitis developed in a soft contact-lens wearer. It grows extremely slowly on various Culture media.
HSIEH, HUEI-MEI;JU, YU-MING;HSUEH, PO- REN;LIN, HSIU-YI;HU, FUNG-RONG;CHEN, WEI-LI   +1 more
core  

Microscopic Identification of Etiological Agents of Mycotic Keratitis in Corneal Ulcer Patients at Tertiary Care Eye Hospital, Pondicherry

open access: yes, 2020
Fungal keratitis is one of the causes of severe ocular morbidity and blindness. The prevalence of fungal keratitis has been increased from 7–63%. Culture is mandatory for an Ophthalmologist to guide treatment.
Selvaraj Stephen   +3 more
core   +1 more source

Evolving treatments for Sjögren disease: current approaches and emerging targets

open access: yesInternal Medicine Journal, EarlyView.
Abstract Sjögren disease (SjD) is a prevalent systemic autoimmune condition characterised by exocrine gland dysfunction, systemic inflammation and heterogeneous organ involvement. Current management remains largely symptomatic, with no approved disease‐modifying therapies available and substantial unmet clinical need. However, advances in understanding
Mansi Bhurani   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy